Company intelligence / Profile preview

Savior Lifetec

Miaoli, Miaoli, Taiwan

Ownership: Private
Employees: ~384
Development stage: Commercial

Overview

Savior Lifetec has a global footprint with products registered in over 80 countries. The company specializes in the development and manufacturing of sterile APIs and finished dosage forms for injectable pharmaceuticals. Its portfolio includes several generic carbapenem antibiotics as well as peptide-based injectables for various indications. No clinical trial results are reported; focus is on commercial supply.

Therapeutic areas: Infectious DiseasesPsychiatryGastroenterologyOphthalmologyWomen's Health
Modalities: Small moleculePeptides
Industry: Biotech

Drug pipeline

2 assets

SLC-037

Preclinical

1 more asset in the full pipeline.

Request access →

Partnerships

not specified publicly; likely partners with global distributors/regional pharma companies due to registrations in >80 countries.

Beyond the preview

Go deeper on Savior Lifetec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Savior Lifetec.

Explore the full profile